ELOVL1-IN-3

2761063-99-2

12352005

ELOVL

Reference compound

Metabolic Enzyme/Protease

Neuroscience-Neuromodulation

Neurological Disease

https://www.medchemexpress.com/elovl1-in-3.html

99.81

DMSO : 100 mg/mL (ultrasonic)

[C@@H]1(C2=CC=CC=C2)OCCN(C3=CC(O[C@@H]4C[C@H](N5C=CC=N5)C4)=NC=N3)C1

C21H23N5O2

377.44

[1]Boyd MJ, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64 (24) :17777-17794.

Blue Ice

-20°C, 3 years (Powder)

Reference compound1

No Development Reported